Fall 2022

Rhythio Medical

Irregular heartbeats affect about 5 million Americans and are a leading source of Sudden Cardiac Death, which is the #1 natural cause of death in the United States, despite available treatments. Rhythio Medical is developing the first preventative approach to arrhythmias – an “injectable wire” that improves heart conduction for patients with known damage, to reduce the risk of an irregularity forming.